News coverage about Rite Aid (NYSE:RAD) has been trending somewhat positive this week, according to Accern. Accern rates the sentiment of press coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Rite Aid earned a media sentiment score of 0.09 on Accern’s scale. Accern also assigned media coverage about the company an impact score of 45.3266401552261 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.
Here are some of the headlines that may have impacted Accern Sentiment’s rankings:
A number of brokerages have recently weighed in on RAD. Vetr lowered Rite Aid from a “strong-buy” rating to a “buy” rating and set a $2.47 target price on the stock. in a research report on Thursday, January 11th. Zacks Investment Research raised Rite Aid from a “sell” rating to a “hold” rating in a research report on Monday, February 5th. Finally, Mizuho reaffirmed a “hold” rating on shares of Rite Aid in a research report on Tuesday, April 17th. Two research analysts have rated the stock with a sell rating, six have given a hold rating, one has assigned a buy rating and one has issued a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average price target of $2.33.
Shares of Rite Aid opened at $1.61 on Friday, MarketBeat reports. The company has a current ratio of 1.37, a quick ratio of 0.85 and a debt-to-equity ratio of 2.11. The firm has a market capitalization of $1.74 billion, a P/E ratio of -80.50 and a beta of 1.74.
Rite Aid (NYSE:RAD) last issued its earnings results on Thursday, April 12th. The company reported ($0.01) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.02) by $0.01. Rite Aid had a negative return on equity of 8.25% and a net margin of 3.60%. The company had revenue of $5.39 billion for the quarter, compared to analyst estimates of $5.75 billion. The firm’s revenue was down 8.6% compared to the same quarter last year. research analysts predict that Rite Aid will post 0.04 EPS for the current fiscal year.
Rite Aid Company Profile
Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through Retail Pharmacy and Pharmacy Services segments. The Retail Pharmacy segment sells prescription drugs; and a range of other merchandise, such as over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other everyday and convenience products.
Receive News & Ratings for Rite Aid Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rite Aid and related companies with MarketBeat.com's FREE daily email newsletter.